Navigation Links
Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting
Date:2/23/2009

LIVINGSTON, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it will be exhibiting at the upcoming Chicago Dental Society's 144th Midwinter Meeting in Chicago. In light of its highly successful sales of the STA Single Tooth Anesthesia System(TM) at last year's CDS conference, coupled with four successive quarters of sales growth in 2008, Milestone anticipates an enthusiastic reception at this year's event.

    WHEN:       Thursday, February 26, 2009 - Sunday, March 1, 2009

    WHERE:      Booth #2206
                McCormick Place Lakeside Center
                2301 South Lake Shore Drive
                Chicago, Illinois

    WHO:        Joe Martin, Chief Executive Officer
                Bob Presutti, Vice President of Sales & Marketing
                Scott Mahnken, Director of Marketing

    WHAT:       Demonstrations of the STA Single Tooth Anesthesia
                System(TM) (STA System)

  • Learn first-hand how Milestone is redefining the standard of care for the delivery of local anesthesia by allowing dentists to more comfortably administer all dental injections.
  • Discover how the STA System is helping dentists to increase their earnings through improvements in their dental practice efficiency, which is important in this economic environment.

Members of the press must register at the Press Booth for this event. For details on obtaining Press Credentials, please visit: http://www.cds.org/media. To book a one-on-one meeting or demonstration, please contact Kathy Addison or Tiffany Korkis at Elite Media Group by calling 407-585-1080 or via email at mlss@efcg.net.

The Midwinter Meeting is among the top three dental meetings in the U.S. and one of the top 10 conventions in Chicago. Each year, more than 600 exhibiting companies participate in the meeting, creating one of the largest exhibits of dental products and manufacturers in North America. The theme for the 2009 Midwinter Meeting is "The World of Dental Networking". The 2008 Midwinter Meeting drew more than 34,500 attendees to the city of Chicago, including 7,515 dentists.

About the Chicago Dental Society

The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit their Web site at http://www.cds.org/.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System, a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milesci.com and www.STAis4U.com.

Safe Harbor Statement

This press release may contain forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

                        FOR MORE INFORMATION, PLEASE CONTACT:
                        Elite Financial Communications Group
                           Dodi Handy, President and CEO
                               For Media Inquiries:
            Tiffany Korkis or Kathy Addison, Directors, Elite Media Group
                   407-585-1080 or via email at mlss@efcg.net


'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment
2. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
3. Mission Pharmacal Celebrates Historic Milestone
4. Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J.
5. Concentric Medical Reaches Important Stroke Milestone
6. Hand Transplantation Marks Historical 10-Year Milestone
7. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
8. VideoMD.com Reaches Milestone of 2500 Patient Education Videos
9. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
10. Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product
11. GetWellNetwork Hits Milestone with Patient Pathways Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with their iMedHD2™ Portable ... product is an extension to RMT technology that delivers HD, dynamic, streaming ultrasound ...
(Date:1/19/2017)... ... 19, 2017 , ... WholeHealth is announcing their participation in ... Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in the ... , “We know it’s easy to get carried away when you’re having ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... dermatologist by the American Board of Dermatology and fellowship trained Mohs and cosmetic ... National Institutes of Health, Dr. Li completed his internship in internal medicine at ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is ... modern CTMS workflow designed to seamlessly integrate and streamline the way researchers prepare ... single page, maximizing usability and improving efficiency significantly for users – a first ...
(Date:1/19/2017)... ... 19, 2017 , ... Students interested in video can get a jump start ... will earn a $1,000 scholarship and have his or her video posted on the ... is May 31, with the winner announced on June 9. , The competition is ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 ... appears serious about reducing the FDA,s regulatory strictness ... in the medical drug industry, many of the ... new clinical trials and development of advanced drug ... ahead with recent developments include:  Moleculin Biotech, Inc., ...
(Date:1/19/2017)... CLEVELAND , Jan. 18, 2017  ViewRay, ... the world,s first and only clinical MRI-guided radiation ... gross proceeds of approximately $26.1 million through a ... Puissance Capital Management led the financing and was ... OrbiMed Advisors, LLC and Kearny Venture Partners, and ...
(Date:1/19/2017)...   Synthetic Biologics, Inc. (NYSE MKT: ... to preserve the microbiome to protect and restore ... initiate a Phase 2b/3 adaptive pivotal trial for ... designed to reduce methane production by certain microorganisms ... treat the underlying cause of irritable bowel syndrome ...
Breaking Medicine Technology: